Bolivar Alfonso Vega, Gomez Sonia Sánchez, Merino Paula, Alonso-Bartolomé Pilar, Garcia Estrella Ortega, Cacho Pedro Muñoz, Hoffmeister Jeffrey W
Department of Radiology, Universitary Marqu é s of Valdecilla Hospital, Santander, Spain.
Acta Radiol. 2010 Dec;51(10):1086-92. doi: 10.3109/02841851.2010.520024. Epub 2010 Oct 1.
although mammography remains the mainstay for breast cancer screening, it is an imperfect examination with a sensitivity of 75-92% for breast cancer. Computer-aided detection (CAD) has been developed to improve mammographic detection of breast cancer.
to retrospectively estimate CAD sensitivity and false-positive rate with full-field digital mammograms (FFDMs).
CAD was used to evaluate 151 cases of ductal carcinoma in situ (DCIS) (n=48) and invasive breast cancer (n=103) detected with FFDM. Retrospectively, CAD sensitivity was estimated based on breast density, mammographic presentation, histopathology type, and lesion size. CAD false-positive rate was estimated with screening FFDMs from 200 women.
CAD detected 93% (141/151) of cancer cases: 97% (28/29) in fatty breasts, 94% (81/86) in breasts containing scattered fibroglandular densities, 90% (28/31) in heterogeneously dense breasts, and 80% (4/5) in extremely dense breasts. CAD detected 98% (54/55) of cancers manifesting as calcifications, 89% (74/83) as masses, and 100% (13/13) as mixed masses and calcifications. CAD detected 92% (73/79) of invasive ductal carcinomas, 89% (8/9) of invasive lobular carcinomas, 93% (14/15) of other invasive carcinomas, and 96% (46/48) of DCIS. CAD sensitivity for cancers 1-10 mm was 87% (47/54); 11-20 mm, 99% (70/71); 21-30 mm, 86% (12/14); and larger than 30 mm, 100% (12/12). The CAD false-positive rate was 2.5 marks per case.
CAD with FFDM showed a high sensitivity in identifying cancers manifesting as calcifications or masses. CAD sensitivity was maintained in small lesions (1-20 mm) and invasive lobular carcinomas, which have lower mammographic sensitivity.
尽管乳腺钼靶摄影仍是乳腺癌筛查的主要手段,但它是一种不完美的检查方法,对乳腺癌的敏感性为75% - 92%。计算机辅助检测(CAD)已被开发出来以提高乳腺钼靶摄影对乳腺癌的检测能力。
回顾性评估使用全场数字化乳腺钼靶摄影(FFDM)时CAD的敏感性和假阳性率。
使用CAD对151例经FFDM检测出的导管原位癌(DCIS)(n = 48)和浸润性乳腺癌(n = 103)进行评估。回顾性地根据乳腺密度、钼靶表现、组织病理学类型和病变大小来评估CAD的敏感性。使用200名女性的筛查FFDM评估CAD的假阳性率。
CAD检测出93%(141/151)的癌症病例:在脂肪型乳腺中为97%(28/29),在含有散在纤维腺密度的乳腺中为94%(81/86),在不均匀致密乳腺中为90%(28/31),在极度致密乳腺中为80%(4/5)。CAD检测出98%(54/55)表现为钙化的癌症,89%(74/83)表现为肿块的癌症,以及100%(13/13)表现为混合性肿块和钙化的癌症。CAD检测出92%(73/79)的浸润性导管癌,89%(8/9)的浸润性小叶癌,93%(14/15)的其他浸润性癌,以及96%(46/48)的DCIS。CAD对1 - 10毫米的癌症敏感性为87%(47/54);11 - 20毫米,99%(70/71);21 - 30毫米,86%(12/14);大于30毫米,100%(12/12)。CAD的假阳性率为每例2.5个标记。
FFDM联合CAD在识别表现为钙化或肿块的癌症方面显示出高敏感性。CAD在小病变(1 - 20毫米)和钼靶敏感性较低的浸润性小叶癌中仍保持较高敏感性。